DS-3030 Tuberculosis Worksheet

Medical Examination for Immigrant or Refugee Applicant

DS-3030 Paper Form (7-2014)

Medical Examination for Immigrant or Refugee Applicant

OMB: 1405-0113

Document [docx]
Download: docx | pdf
Shape3 Shape2 Shape1



Photo

OMB No. 1405-0113

EXPIRATION DATE: xx/xx/xxxx

ESTIMATED BURDEN: 20 MINUTES

(See Page 2 – Back of Form)

U.S. Department of State

TUBERCULOSIS WORKSHEET

For use with DS-2054





Name (Last, First, MI)

Age


Birth Date (mm-dd-yyyy)

Passport Number

Alien (Case) Number


  1. Test for Cell-Mediated Immunity to Tuberculosis

Required for applicants 2 through 14 years of age where WHO-estimated TB rate ≥20 per 100,000 and contacts; perform one type only.


Shape5 Shape4
































TST Date applied (mm-dd-yyyy)

Shape7 Shape6
































QFT Nil Value: IU

Shape8

TB Response: TB minus nil IU/ml


Shape10 Shape9
































T-Spot Nil Value: Number of cells

TB Response: Higher of

Shape11

Panel A or Panel B minus nil value


Shape12

Result (mm)

Shape14 Shape13
































IGRA Date drawn (mm-dd-yyyy)

Shape15
































Positive

Shape16
































Negative

Shape17
































Indeterminant, Borderline, or Equivocal


  1. Chest X-Ray Indication (Mark all that apply)



Shape18


Date Chest X-Ray Taken (mm-dd-yyyy)


Shape19
































Chest X-Ray not indicated

Shape20
































Age >15 years

Shape21
































Signs or symptoms of tuberculosis

Shape22
































Known HIV infection

Shape23
































TST ≥10 mm or IGRA positive

Shape24
































Contact: TST > 5 mm or IGRA positive


3. Chest X-Ray Findings

Shape25
































Normal Findings

Shape26
































Abnormal Findings (Indicate category and finding, checking all that apply in the tables below)


Can Suggest Tuberculosis (Need Smears and Cultures)

No Sputum Specimens Required



Shape27
































Infiltrate or consolidation

Shape28
































Cavitary lesion

Shape29
































Nodule or mass with poorly defined margins (such as tuberculoma)

Shape30
































Pleural effusion (perform lateral or decubitus radiograph or ultrasound, if needed)




Shape31
































Hilar/mediastinal adenopathy

Shape32
































Miliary findings

Shape33
































Discrete linear opacity

Shape34
































Discrete nodule(s) without calcification

Shape35
































Volume loss or retraction

Shape36
































Other

Mark as Class B Other on DS 2054

Shape37
































Cardiac

Shape38
































Musculoskeletal

Shape39
































Other, specify in Remarks


Do not mark as Class B Other on DS 2054

Shape40
































Pleural thickening

Shape41
































Diaphragmatic tenting

Shape42
































Calcified pulmonary nodule(s)

Shape43
































Calcified lymph node(s)


Remarks


Shape44



Shape45


Shape46 Shape47 Shape48


Radiologist’s Name (Printed) Radiologist's Signature (Required) Date Interpreted (mm-dd-yyyy)


4. Sputum Smears and Cultures Decision

Shape49
































No, not indicated - Applicant has no signs or symptoms of TB, no known HIV infection, and:

Shape50
































X-ray Normal or ‘No specimens required' and test for cell-mediated immunity to TB negative (if performed)

Shape51
































X-ray Normal or ‘No specimens required’ and test for cell-mediated immunity to TB positive (if performed)

Shape52
































Yes, are indicated - Applicant has (Mark all that apply):

Shape53
































Signs or symptoms of TB

Shape54
































Chest X-ray suggests TB

Shape55
































Known HIV infection

Shape56
































End of treatment cultures


5. Sputum Smears and Cultures Results


Sputum

Smear

Results

Date specimen obtained (mm-dd-yyyy)

Date specimen reported

(mm-dd-yyyy)


Positive


Negative

1.




2.




3.





Sputum

Culture

Results

Date specimen obtained

(mm-dd-yyyy)

Date specimen reported (mm-dd-yyyy)

*Date of exam on DS 2054


Positive


Negative


NTM


Contaminated

1.






2.






3.










6. Tuberculosis Classification

Applicants may have more than one TB Classification. However, they cannot be classified as both Class B1 TB and Class B2 TB. In addition, applicants cannot be classified as Class B3 TB, Contact Evaluation if they are Class A or Class B1 TB, Extrapulmonary.


Shape57

































No TB Classification

CXR not suggestive of tuberculosis, no signs or symptoms, no known HIV infection, TST or IGRA negative (if performed), not a contact

Shape58


































Class A

Applicant has tuberculosis disease


Shape59

































Class B1 TB, Pulmonary

CXR suggests tuberculosis, or signs and symptoms, or known HIV infection and sputum smears and cultures are negative and not a clinically diagnosed case.

Shape60


































Class B1 TB, Extrapulmonary

Applicants with evidence of extrapulmonary tuberculosis. The anatomic site of infection should be documented.


Shape61

Anatomic Site of Disease

Shape62

































No treatment

Shape63

































Current treatment

Shape64

































Completed treatment

Shape65


































Class B2 TB, LTBI Evaluation

Applicants who have a tuberculin skin test ≥10 mm or positive IGRA but otherwise have a negative evaluation for tuberculosis. Contacts with TST ≥5 mm or positive IGRA should receive this classification (if they are not already Class B1 TB, Pulmonary).


Shape66

































No LTBI treatment

Shape67

































Current LTBI treatment (Indicate medications in Part 7)

Shape68

































Completed LTBI treatment (Indicate medications in Part 7)


Shape69

































Class B3 TB, Contact Evaluation

Applicants who are a recent contact of a known tuberculosis case.


Shape70

































No preventive treatment

Shape71

































Current preventive treatment (Indicate medications in Part 7)

Shape72

































Completed preventive treatment (Indicate medications in Part 7)


Source Case:

Shape73

Name

Shape74

Alien Number

Shape75

Relationship to Contact

Shape76

Date Contact Ended (mm-dd-yyyy)


Type of Source Case TB (Mark only one and attach DST results)

Shape77

































Pansusceptible TB

Shape78

































MDR TB (resistant to at least INH and rifampin)

Shape79 Shape80

































































Drug-resistant TB other than MDR TB Culture negative

Shape81

































Culture results not available



Remarks


Shape82



Shape83


Shape89 Shape88 Shape84 Shape87 Shape86 Shape85




7. Previous Tuberculosis Diagnosis and Treatment History for Applicants Diagnosed or Treated Through Panel Physician

Complete this section only if one of the following is true (mark appropriate option):

Shape90

































Applicant was diagnosed with tuberculosis disease by the panel physician

Shape91

































Applicant was on tuberculosis treatment at the time of presentation for their medical examination


Shape93 Shape92

































































How was the diagnosis made: Positive laboratory tests Clinical diagnosis


Diagnostic Chest Radiograph


Shape94

Facility performing chest radiograph:



Shape95

Date Radiograph obtained (mm-dd-yyyy):

Findings Present

Shape96
































Infiltrate or consolidation


Shape97
































Cavitary lesion


Shape98
































Nodule or mass with poorly defined margins (such as tuberculoma)


Shape99
































Hilar/mediastinal adenopathy


Shape100
































Pleural effusion

Shape101
































Miliary findings


Shape102
































Discrete linear opacity


Shape103
































Discrete nodule(s) without calcification

Shape104

































Volume loss or retraction


Shape105
































Other


Shape106
































Normal or no findings suggestive of tuberculosis


Sputum Smear Results

Date specimen obtained (mm-dd-yyyy)

Date specimen reported

(mm-dd-yyyy)


Positive


Negative

1.




2.




3.





Sputum Culture Results

Date specimen obtained

(mm-dd-yyyy)

Date specimen reported

(mm-dd-yyyy)



Positive



Negative



NTM



Contaminated

1.






2.






3.







Drug Susceptibility Test Results. Attach with DS Forms.


Method of DST:

Date specimen obtained

(mm-dd-yyyy)

Date DST reported

(mm-dd-yyyy)

Shape107
































MGIT

Shape108
































Agar

Shape109
































LJ







Drug

Susceptible

Resistant

Required for first-line DST

Isoniazid



Rifampin



Ethambutol



Pyrazinamide



Required for multidrug-resistant cases

Ethionamide



Amikacin



Capreomycin



Para-aminosalycilic acid (PAS)



Shape110

Fluoroquinolone, specify:




Other, specify:


















7. Previous Tuberculosis Diagnosis and Treatment History for Applicants Diagnosed or Treated Through Panel Physician, Continued


Were molecular tests used in addition to the required sputum smears, cultures, and DST:

Shape111

































No

Shape112

































Yes (mark all that apply):




Molecular Test

Mycobacterium tuberculosis

Rifampin

Resistance

Isoniazid

Resistance



Second-Line Test

Positive

Negative

Positive

Negative

Positive

Negative

Shape113
































Hain Line Probe Assay







Shape114
































Performed, attach results

Shape115
































GeneXpert







Tuberculosis Treatment

Treating physician or institution


Shape116 Shape117
































DGMQ-Designated DOT site:


Shape119 Shape118
































Non-DGMQ-Designated DOT site:

Drug

Dosage

Start Date (mm-dd-yyyy)

End Date (mm-dd-yyyy)

Isoniazid




Rifampin




Ethambutol




Pyrazinamide




Other, specify:































PAPERWORK REDUCTION ACT AND CONFIDENTIALITY STATEMENTS


PAPERWORK REDUCTION ACT STATEMENT


Public reporting burden for this collection of information is estimated to average 20 minutes per response, including time required for searching existing data sources, gathering the necessary documentation, providing the information and/or documents required, and reviewing the final collection. You do not have to supply this information unless this collection displays a currently valid OMB control number. If you have comments on the accuracy of this burden estimate and/or recommendations for reducing it, please send them to [email protected]


CONFIDENTIALITY STATEMENT


AUTHORITIES: The information asked for on this form is requested pursuant to Section 212(a) and 221(d) and as required by Section 222 of the Immigration and Nationality Act. Section 222(f) provides that the records of the Department of State and of diplomatic and consular offices of the United States pertaining to the issuance and refusal of visas or permits to enter the United States shall be considered confidential and shall be used only for the formulation, amendment, administration, or enforcement of the immigration, nationality, and other laws of the United States. Certified copies of such records may, in the discretion of the Secretary of State, be made available to a court provided the court certifies that the information contained in such records is needed in a case pending before the court.


PURPOSE: The U.S. Department of State uses the facts you provide on this form primarily to determine your classification and eligibility for a U.S. immigrant visa. Individuals who fail to submit this form or who do not provide all the requested information may be denied a U.S. immigrant visa. Although furnishing this information is voluntary, failure to provide this information may delay or prevent the processing of your case.


ROUTINE USES: If you are issued an immigrant visa and are subsequently admitted to the United States as an immigrant, the Department of Homeland Security will use the information on this form to issue you a Permanent Resident Card, and, if you so indicate, the Social Security Administration will use the information to issue a social security number. The information provided may also be released to federal agencies for law enforcement, counterterrorism and homeland security purposes; to Congress and courts within their sphere of jurisdiction; and to other federal agencies who may need the information to administer or enforce U.S. laws. More information on the Routine Uses for this collection can be found in the System of Records Notice State-24, Medical Records.




Shape120

DRAFT6

DS-3030 Page 1 of 1

08-2011

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorCDC User
File Modified0000-00-00
File Created2021-01-25

© 2024 OMB.report | Privacy Policy